- Home
- Supplements
- Fiber Supplements
- Type 2 Diabetes
Fiber Supplements for Type 2 Diabetes
Meta-analyses of randomized trials find viscous and soluble fiber supplements lower HbA1c by roughly 0.5-0.6 percentage points and fasting glucose in adults with type 2 diabetes, as an add-on to diet and medication. The effect is modest and the trials differ.
Overview
Verdict
Fiber supplements, especially viscous (gel-forming) and soluble types, lower HbA1c by about 0.5-0.6 percentage points and fasting glucose in adults with type 2 diabetes, on top of usual care. The effect is real but modest, and the trials differ widely.
The short answer
Yes, with limits. A 2019 meta-analysis of 28 trial comparisons (1,394 adults) found that viscous fiber at a median of about 13 g a day lowered HbA1c by 0.58 percentage points and fasting glucose by 0.82 mmol/L, in addition to standard care (Jovanovski 2019). A 2021 meta-analysis of soluble fiber supplements reached a similar figure, -0.63 percentage points across 29 trials (Xie 2021).
That is helpful as an add-on and smaller than most glucose-lowering drugs, so fiber supplements do not replace medication, diet or activity. They also work best when glucose is high: in the psyllium analysis, people with normal glucose saw no meaningful change (Gibb 2015). For the wider picture, see our pages on type 2 diabetes and fiber supplements.
Who this page is for
Adults with type 2 diabetes who want to know whether a fiber supplement is worth adding to diet and medication. It is not a reason to change or stop prescribed treatment, and the evidence is weaker for type 1 diabetes and for children.
At a glance
- Verdict
- Likely helpful as an add-on (moderate evidence)
- Typical effect
- HbA1c down about 0.55-0.63 percentage points
- Doses studied
- About 8-15 g a day of supplemental fiber
- Best-supported types
- Viscous fibers such as psyllium; soluble fiber overall
- Time to judge
- 8-12 weeks (HbA1c lags about 3 months)
- Main side effects
- Gas and bloating; none reported in the small psyllium trials
How It Works
Slower carbohydrate absorption
Viscous fibers such as psyllium and glucomannan thicken in water. In the gut that gel slows how fast food leaves the stomach and how quickly carbohydrate is absorbed, which blunts the glucose spike after a meal. This is the standard explanation for why trials dosed psyllium before meals (Gibb 2015).
The glucomannan trial in type 2 diabetes measured fructosamine (a marker of glucose over the previous 2-3 weeks) and found it fell 5.7% versus placebo, in line with that idea (Vuksan 1999).
What the mechanism can't tell you
Gut bacteria that ferment fiber, effects on fullness and body weight, and lower insulin resistance are all proposed extra routes. Meta-analyses did find lower fasting insulin and HOMA-IR and slightly lower BMI (Xie 2021), but the trials do not show which route matters, and fermentable fibers such as inulin may work differently from gel-forming ones (Wang 2019).
So the mechanism is a reason to expect an effect, not proof of one. The proof is the HbA1c and glucose data in the evidence section.
Proposed mechanisms
Fiber type matters
Viscous, gel-forming fibers (psyllium, glucomannan) and soluble fibers have the trial data. Insoluble fibers such as wheat bran were not the focus of these meta-analyses.
Dosing & Protocol
Doses used in the trials
Doses vary by fiber type. The pooled median for viscous fiber was about 13.1 g a day (Jovanovski 2019), while a dose-response analysis of soluble fiber pointed to 7.6-8.3 g a day (Xie 2021). Inulin-type fructans were recommended at 10 g a day for 6 weeks or longer (Wang 2019).
The small psyllium trials gave 5.1 g twice a day before breakfast and dinner for 8 weeks (Ziai 2005), and 10 g twice a day baked into cookies for 12 weeks (Noureddin 2018). Check with your clinician before starting, especially if you take insulin or a sulfonylurea. Supplement fiber also counts toward your total fiber intake, so see the main fiber page for dose context.
Dose by situation
| Situation | Dose | Form | Notes |
|---|---|---|---|
| Pooled viscous fiber trials | About 13 g/day (median) | Viscous fiber, e.g. psyllium | 28 trial comparisons; HbA1c -0.58 points |
| Soluble fiber dose-response | 7.6-8.3 g/day | Soluble fiber supplements | Best fit in a dose-response analysis |
| Psyllium, add-on to drugs | 5.1 g twice daily, before breakfast and dinner | Psyllium husk | 8 weeks, double-blind, placebo-controlled |
| Psyllium with constipation | 10 g twice daily | Psyllium baked in cookies | 12 weeks, single-blind |
| Inulin-type fructans | 10 g/day for 6+ weeks | Inulin or FOS powder | Pooled prediabetes and type 2 diabetes data |
Doses are those reported in the trials and meta-analyses cited on this page, not individual advice.
How to try it
- 1
Check first· Before starting
Ask your prescriber or pharmacist, especially if you use insulin or a sulfonylurea, because fiber can add to glucose lowering.
- 2
Start low· Weeks 1-3
Begin with a small amount of a viscous fiber such as psyllium, taken with a full glass of water, and increase every week or so to limit gas and bloating.
- 3
Time it before meals· Ongoing
The psyllium trials gave it before meals; the Ziai trial used 30 minutes before breakfast and dinner.
- 4
Track your numbers· Weeks 1-12
Log fasting and post-meal glucose, and bring them to your next HbA1c check.
- 5
Judge at 8-12 weeks· Week 8-12
If glucose and HbA1c have not moved and you have side effects, stop or ask about another approach.
Food first
The ADA Standards of Care encourage at least 14 g of fiber per 1,000 kcal from food, with at least half of grains whole (ADA Standards of Care 2026). A supplement helps close the gap, not replace vegetables, legumes and whole grains.
Evidence
The meta-analyses
The pooled trials point the same way. Viscous fiber: HbA1c -0.58 points and fasting glucose -0.82 mmol/L in 1,394 adults, GRADE certainty moderate (Jovanovski 2019). Soluble fiber: HbA1c -0.63 points, fasting glucose -0.89 mmol/L, 2-hour post-meal glucose and fasting insulin all lower in 1,517 adults (Xie 2021). An earlier analysis of 11 trials, with fiber from food or supplements up to 15 g a day, found HbA1c lower by 0.55 points (Silva 2013).
A broader review of dietary fibre in diabetes also found lower HbA1c, fasting glucose, cholesterol, weight and inflammation markers with higher intake, and fewer deaths in cohort data, though every trial analysis had high heterogeneity (Reynolds 2020).
Psyllium trials
A meta-analysis of 35 trials found psyllium dosed before meals cut fasting glucose by 37.0 mg/dL and HbA1c by 0.97% in people treated for type 2 diabetes, with no effect in people with normal glucose (Gibb 2015). The authors included clinical records held by the maker of a psyllium product, so independent replication matters.
In an 8-week double-blind trial of 49 adults on antidiabetic drugs, 5.1 g twice a day lowered fasting glucose and HbA1c (Ziai 2005). In 12-week single-blind trials in constipated adults with type 2 diabetes, psyllium baked in cookies lowered glucose and weight versus placebo (Noureddin 2018) (Soltanian 2019).
Glucomannan and inulin
Six trials (440 adults) of glucomannan found lower fasting and post-meal glucose, fasting insulin and fructosamine (Zhang 2023). The oldest trial was a small crossover study of 11 adults (Vuksan 1999). Inulin-type fructans lowered HbA1c by 0.58% in a 33-trial analysis of people with prediabetes or type 2 diabetes, though subgroup results depended on the type of inulin (Wang 2019). See our inulin page.
What's missing
Almost all trials last 3 to 24 weeks, so long-term effects on HbA1c, complications and weight are unknown. Heterogeneity is high, many included trials are small, and the abstracts we read do not report hypoglycemia rates. No head-to-head trial in people with type 2 diabetes compares psyllium with glucomannan or inulin.
Evidence scorecard
- Viscous fiber, HbA1c
- -0.58 points (28 comparisons, moderate certainty)
- Soluble fiber, HbA1c
- -0.63 points (29 trials, high heterogeneity)
- Psyllium, fasting glucose
- -37.0 mg/dL in treated type 2 diabetes
- Inulin-type fructans, HbA1c
- -0.58% (prediabetes and type 2 diabetes)
- Glucomannan
- Lower fasting and post-meal glucose (6 trials, n = 440)
- Long-term outcomes
- Not shown
Meta-analyses and randomized trials of fiber supplements (and, in two cases, dietary fibre) in people with type 2 diabetes.
Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients
Ziai SA, Larijani B, Akhoondzadeh S +4 more
5.1g b.i.d. of psyllium for persons with type II diabetes is safe, well tolerated
Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials
Jovanovski E, Khayyat R, Zurbau A +4 more
Viscous fiber supplements improve conventional markers of glycemic control beyond usual care
Effects of Glucomannan Supplementation on Type II Diabetes Mellitus in Humans: A Meta-Analysis
Zhang Z, Zhang Y, Tao X +3 more
glucomannan is an effective nutritional intervention for type II diabetes
Effects of psyllium vs. placebo on constipation, weight, glycemia, and lipids: A randomized trial in patients with type 2 diabetes and chronic constipation
Noureddin S, Mohsen J, Payman A
no adverse effects were observed
Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial
Vuksan V, Jenkins DJ, Spadafora P +4 more
KJM fiber added to conventional treatment may ameliorate glycemic control
Effect of flaxseed or psyllium vs. placebo on management of constipation, weight, glycemia, and lipids: A randomized trial in constipated patients with type 2 diabetes
Soltanian N, Janghorbani M
no adverse effects were observed
Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses
Reynolds AN, Akerman AP, Mann J
Higher-fibre diets are an important component of diabetes management
Effects of soluble fiber supplementation on glycemic control in adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
Xie Y, Gou L, Peng M +2 more
a daily dosage of 7.6-8.3 g was recommended
Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials
Silva FM, Kramer CK, de Almeida JC +3 more
increased fiber intake improved glycemic control
Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus
Gibb RD, McRorie JW, Russell DA +2 more
no significant glucose lowering was observed in euglycemic subjects
Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: a GRADE-assessed systematic review and dose-response meta-analysis of 33 randomized controlled trials
Wang L, Yang H, Huang H +5 more
a daily dose of 10 g for a duration of 6 weeks
Safety
Tolerability
The small psyllium trials reported good tolerability and no adverse effects (Noureddin 2018) (Soltanian 2019), and one reported better gastric tolerance to metformin with psyllium (Ziai 2005). Gas and bloating are the usual complaints with any fiber supplement, more so with fermentable types such as inulin. Build up slowly, drink plenty of water and check the fiber supplements page for the full safety picture.
If you use insulin or a sulfonylurea
Fiber lowered glucose beyond standard care in the trials. If you take insulin or a drug that can cause low blood sugar, tell your care team before starting and check your glucose more often at first.
Check with your clinician first if you
Interactions & Conflicts
Fiber's main interaction is additive: it can strengthen the glucose-lowering effect of diabetes drugs. The pooled trials measured its effect on top of standard care (Jovanovski 2019), and one trial ran with antidiabetic drugs (Ziai 2005). Interactions beyond glucose were not studied in the sources read here, so the second row is a precaution.
Notable interactions
| Interacts with | Severity | Mechanism | Action |
|---|---|---|---|
| Insulin and sulfonylureas | moderate | Additive glucose lowering, with a possible low-blood-sugar risk | Check glucose more often at the start and tell your prescriber |
| Other oral medicines | low | Gel-forming fiber may slow absorption (precaution, not tested in the trials cited here) | Take medicines at a different time from fiber and ask your pharmacist |
| Metformin | low | Better gastric tolerance recorded with psyllium in one trial | No change needed; mention it to your prescriber |
References
- Jovanovski E, et al. Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2019;42(5):755-766.DOI: 10.2337/dc18-1126
- Xie Y, et al. Effects of soluble fiber supplementation on glycemic control in adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2021;40(4):1800-1810.DOI: 10.1016/j.clnu.2020.10.032
- Silva FM, et al. Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev. 2013;71(12):790-801.DOI: 10.1111/nure.12076
- Reynolds AN, et al. Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. PLoS Med. 2020;17(3):e1003053.DOI: 10.1371/journal.pmed.1003053
- Gibb RD, et al. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr. 2015;102(6):1604-14.DOI: 10.3945/ajcn.115.106989
- Ziai SA, et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 2005;102(2):202-7.DOI: 10.1016/j.jep.2005.06.042
- Noureddin S, et al. Effects of psyllium vs. placebo on constipation, weight, glycemia, and lipids: A randomized trial in patients with type 2 diabetes and chronic constipation. Complement Ther Med. 2018;40:1-7.DOI: 10.1016/j.ctim.2018.07.004
- Soltanian N, et al. Effect of flaxseed or psyllium vs. placebo on management of constipation, weight, glycemia, and lipids: A randomized trial in constipated patients with type 2 diabetes. Clin Nutr ESPEN. 2019;29:41-48.DOI: 10.1016/j.clnesp.2018.11.002
- Zhang Z, et al. Effects of Glucomannan Supplementation on Type II Diabetes Mellitus in Humans: A Meta-Analysis. Nutrients. 2023;15(3).DOI: 10.3390/nu15030601
- Vuksan V, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care. 1999;22(6):913-9.DOI: 10.2337/diacare.22.6.913
- Wang L, et al. Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: results from a GRADE-assessed systematic review and dose-response meta-analysis of 33 randomized controlled trials. J Transl Med. 2019;17(1):410.DOI: 10.1186/s12967-019-02159-0
- American Diabetes Association Professional Practice Committee. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S89.
Frequently Asked Questions
Can fiber supplements lower HbA1c in type 2 diabetes?
Does psyllium help blood sugar in type 2 diabetes?
Which fiber supplement is best for type 2 diabetes?
How much fiber supplement should someone with type 2 diabetes take?
Is it safe to take fiber supplements with metformin or insulin?
Do fiber supplements replace eating more fiber from food?
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.